| Style | Citing Format |
|---|---|
| MLA | Safavi AS, et al.. "Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application." Materials Chemistry and Physics, vol. 355, no. , 2026, pp. -. |
| APA | Safavi AS, Karbasi S, Poursamar A, Nasr Azadani R, Haghighipour N (2026). Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application. Materials Chemistry and Physics, 355(), -. |
| Chicago | Safavi AS, Karbasi S, Poursamar A, Nasr Azadani R, Haghighipour N. "Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application." Materials Chemistry and Physics 355, no. (2026): -. |
| Harvard | Safavi AS et al. (2026) 'Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application', Materials Chemistry and Physics, 355(), pp. -. |
| Vancouver | Safavi AS, Karbasi S, Poursamar A, Nasr Azadani R, Haghighipour N. Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application. Materials Chemistry and Physics. 2026;355():-. |
| BibTex | @article{ author = {Safavi AS and Karbasi S and Poursamar A and Nasr Azadani R and Haghighipour N}, title = {Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application}, journal = {Materials Chemistry and Physics}, volume = {355}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Safavi AS AU - Karbasi S AU - Poursamar A AU - Nasr Azadani R AU - Haghighipour N TI - Fabrication and Characterization of Chitosan-Poly (3-Hydroxybutyrate) Scaffold As a Novel 3D-Printed Platform for Bone Tissue Engineering Application JO - Materials Chemistry and Physics VL - 355 IS - SP - EP - PY - 2026 ER - |